Vimarsana
Biggest News Aggregation in the World

Johnw Osborn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnw Osborn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnw Osborn Today - Breaking & Trending Today

John W. Osborn Jr. - The Martha's Vineyard Times - Vimarsana News

John W. Osborn Jr. - The Martha's Vineyard Times

John W. Osborn, Jr., 92, of Mechanicsburg, Pa., passed away on Friday, March 29, 2024, at Holy Spirit Hospital.  Born on August 13, 1931, in Oak Bluffs, he was the son of Elizabeth E. (House) and John W. Osborn Sr. John worked as a salesman for Powernail, as well as a sales manager for Inland Container […]

Thomas Martin Osborn - Vimarsana News

Thomas Martin Osborn

Warren, Pa. — Thomas Martin Osborn, 82, of Cobham Park Road, Warren, Pennsylvania, passed away at St. Vincent Hospital in Erie on June 18, 2023 after a brief illness.

BioSig Technologies : Annual report pursuant to Section 13 and 15(d) - Vimarsana News

BioSig Technologies : Annual report pursuant to Section 13 and 15(d)

Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases , which amended... | March 31, 2023

BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of MinnesotaNeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease - Vimarsana News

BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of MinnesotaNeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease

Published: Dec 18, 2020 Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company and its NeuroClear Technologies division signed a new research agreement with the University of Minnesota.  Under the terms of the agreement, the Company intends to launch a program to develop novel therapies to treat...

BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota - Vimarsana News

BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota

BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota Westport, CT, Dec. 18, 2020 — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company and its NeuroClear Technologies division signed a new ...